The progression of neuronal, myelin, astrocytic, and immunological changes in the rat brain following exposure to aurothioglucose

Brain Research

Volumn 949, Issue 1-2, 2002, Pages 171-177

  Schmued, Larry C ^a  

^a NATIONAL CENTER FOR TOXICOLOGICAL RESEARCH   (United States)

Author keywords

Blood brain barrier; Circumventricular organ; Gold therapeutics; Gold thioglucose; Neuropathology

Indexed keywords

AUROTHIOGLUCOSE; MYELIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ASTROCYTE; BRAIN; BRAIN REGION; CELL POPULATION; CELL TYPE; CONTROLLED STUDY; DISEASE COURSE; DISEASE MARKER; GLIA CELL; INFLAMMATION; MALE; NERVE CELL; NERVE CELL NECROSIS; NEUROIMMUNOLOGY; NEUROPATHOLOGY; NEUROTOXICITY; NONHUMAN; PRIORITY JOURNAL; RAT;

ANIMALS; ASTROCYTES; AUROTHIOGLUCOSE; GLIAL FIBRILLARY ACIDIC PROTEIN; HYPOTHALAMUS; IMMUNOHISTOCHEMISTRY; MALE; MEDULLA OBLONGATA; MYELIN SHEATH; NEURONS; RATS; RATS, SPRAGUE-DAWLEY; TIME FACTORS;

EID: 0037072515     PISSN: 00068993     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0006-8993(02)02978-5     Document Type: Article

References (14)

1. Arees E.A., Veltman B.I., Mayer J. Hypothalamic blood flow following goldthioglucose induced lesions. Exp. Neurol. 25:1969;410-415.
2. Brechler G., Waxler S. Obesity in albino mice due to single injections of goldthioglucose. Proc. Soc. Exp. Med. 70:1949;498-501.
3. Caffyn Z.E.Y. Ultrastructural changes induced in the hypothalamus of the mouse by goldthioglucose. Br. J. Exp. Pathol. 52:1971;517-523.
4. Caffyn Z.E.Y. Early vascular changes in the brain of the mouse after injections of goldthioglucose and biperidyl mustard. J. Pathol. 106:1972;49-56.
5. Caffyn Z.E.Y. The inhibition of goldthioglucose and bipiperidyl mustard-induced hypothalamic lesions by anti-inflammatory agents. J. Pathol. 106:1972;57-63.
6. Luse S., Harris B., Stohr P. Ultrastructural evidence for oligodendroglial transport of salt and glucose. Anat. Rec. 139:1961;250.
7. Marshall N., Mayer J., Burnett R. Hypothalamic lesions in goldthioglucose-injected mice. Proc. Soc. Exp. Biol. Med. 90:1955;240.
8. Mayer J., Marshall N.B. Specificity of goldthioglucose for ventromedial hypothalamic lesions and hyperphagia. Nature. 178:1956;1399-1400.
9. Mayer J., Marshall N.B. Mode d'action de l'aurothioglucose et regulation glucostatique de la nutrition. C. R. Acad. Sci. 242:1956;169.
10. Perry J.H., Liebelt R.A. Extra-hypothalamic lesions associated with goldthioglucose. Proc. Soc. Exp. Biol. Med. 106:1961;55-57.
11. Schmued L.C., Slikker W.S. Jr. Black-Gold: a simple, high-resolution label for normal and pathological myelin in brain tissue sections. Brain Res. 837:1999;289-297.
12. Schmued L.C., Hopkins K.J. Fluoro-Jade B: a high affinity fluorescent marker for the localization of neuronal degeneration. Brain Res. 874:2000;123-130.
13. Shaw G.F., Schraa S., Gleichmann E., Grover Y.P., Dunnemann L., Jagarlamudi A. Shaw G.F., Metal Based Drugs. Vol. 1:1994;351-362 Freund, London.
14. Wagner J.W., de Groot J. Effect of goldthioglucose injections on survival, organ-damage and obesity in the rat. Proc. Soc. Exp. Biol. Med. 112:1963;33-37.